Adaptimmune Therapeutics PLC (ADAP)

0.6048 0.00 (0.00%) USD  |  NASDAQ  |  Dec 20, 16:00
0.5958 -0.01 (-1.49%) Pre-Market: 20:00
More

Adaptimmune Therapeutics Price to Book Value: 1.935 for Dec. 20, 2024

Price to Book Value Chart

View Price to Book Value for ADAP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price to Book Ratio Definition

View Price to Book Ratio Definition
Start Trial

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Biodexa Pharmaceuticals PLC 0.2052
NuCana PLC 0.8095
TC BioPharm (Holdings) PLC 2.163
Verona Pharma PLC 26.38
Autolus Therapeutics PLC 1.278

Price to Book Value Related Metrics

PS Ratio 0.8508
Price 0.6048
Earnings Yield -29.76%
Market Cap 154.76M